Crossmark

Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network

Crossref DOI link: https://doi.org/10.1007/s10803-016-2877-3

Published Online: 2016-07-27

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bilder, Deborah A.

Bakian, Amanda V.

Stevenson, David A.

Carbone, Paul S.

Cunniff, Christopher

Goodman, Alyson B.

McMahon, William M.

Fisher, Nicole P.

Viskochil, David
Funding

Funding for this research was provided by:

Centers for Disease Control and Prevention (UR3 DD000685-04/DD10-1002)
License Information

Text and Data Mining valid from 2016-07-27

Version of Record valid from 2016-07-27
More Information

Article History

First Online: 27 July 2016

Compliance with Ethical Standards

:

: All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Document is current

Any future updates will be listed below